| Accession |
PRJCA014674 |
| Title |
SHR-1905-101-Phase I clinical trial of Safety, tolerability, pharmacokinetics, and pharmacodynamics of a single subcutaneous injection of SHR-1905 in healthy subjects and asthmatic patients |
| Relevance |
Medical |
| Data types |
Clinical, imaging, metabolic, biomarker data, etc
|
| Organisms |
Homo sapiens
|
| Description |
SHR-1905-101-Safety, tolerability, pharmacokinetics, and pharmacodynamics of a single subcutaneous injection of SHR-1905 in healthy subjects and patients with asthma: a randomized, double-blind, dose-increasing, placebo-controlled Phase I trial |
| Sample scope |
Multiisolate |
| Release date |
2023-02-01 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
weiqing ge
weiqing
ge (weiqing.ge@hengrui.com)
|
| Organization |
Jiangsu Hengrui pharmaceutical Co.LTD |
| Submission date |
2023-02-01 |
